Roche Holding Ltd. (RHHBY) Receives Average Recommendation of “Hold” from Analysts

Shares of Roche Holding Ltd. (OTCMKTS:RHHBY) have received an average recommendation of “Hold” from the fifteen research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $38.00.

Several research firms recently weighed in on RHHBY. Zacks Investment Research cut shares of Roche from a “buy” rating to a “hold” rating in a research report on Friday. JPMorgan Chase & Co. restated an “overweight” rating on shares of Roche in a research report on Friday, December 29th. Piper Jaffray Companies restated a “buy” rating on shares of Roche in a research report on Thursday, December 7th. Berenberg Bank cut shares of Roche from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. Finally, Citigroup cut shares of Roche from a “buy” rating to a “neutral” rating in a research report on Wednesday, October 18th.

Several institutional investors have recently modified their holdings of RHHBY. Stonebridge Capital Advisors LLC bought a new stake in shares of Roche in the 3rd quarter valued at $221,000. New England Research & Management Inc. increased its position in shares of Roche by 11.6% in the 4th quarter. New England Research & Management Inc. now owns 26,257 shares of the company’s stock valued at $829,000 after buying an additional 2,730 shares in the last quarter. Patten Group Inc. increased its position in shares of Roche by 12.2% in the 3rd quarter. Patten Group Inc. now owns 29,741 shares of the company’s stock valued at $847,000 after buying an additional 3,239 shares in the last quarter. Chickasaw Capital Management LLC increased its position in shares of Roche by 33.3% in the 4th quarter. Chickasaw Capital Management LLC now owns 40,000 shares of the company’s stock valued at $1,265,000 after buying an additional 10,000 shares in the last quarter. Finally, Sterling Capital Management LLC increased its position in shares of Roche by 4.6% in the 3rd quarter. Sterling Capital Management LLC now owns 58,107 shares of the company’s stock valued at $1,856,000 after buying an additional 2,535 shares in the last quarter. Institutional investors own 0.58% of the company’s stock.

Roche (OTCMKTS RHHBY) traded down $0.21 during mid-day trading on Tuesday, reaching $31.83. 900,805 shares of the company traded hands, compared to its average volume of 1,670,000. The company has a quick ratio of 0.92, a current ratio of 1.29 and a debt-to-equity ratio of 0.66. Roche has a 1 year low of $28.48 and a 1 year high of $36.82. The company has a market cap of $219,510.00, a PE ratio of 22.10, a PEG ratio of 2.23 and a beta of 0.67.

TRADEMARK VIOLATION NOTICE: “Roche Holding Ltd. (RHHBY) Receives Average Recommendation of “Hold” from Analysts” was first posted by Markets Daily and is owned by of Markets Daily. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.themarketsdaily.com/2018/01/09/roche-holding-ltd-rhhby-receives-average-recommendation-of-hold-from-analysts.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply